ScreenIT
The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.
Latest preprint reviews
-
Cohort Profile: The United Kingdom Research study into Ethnicity and COVID-19 outcomes in Healthcare workers (UK-REACH)
This article has 37 authors:Reviewed by ScreenIT
-
Defining the substrate envelope of SARS-CoV-2 main protease to predict and avoid drug resistance
This article has 13 authors:Reviewed by ScreenIT
-
Determinants of SARS-CoV-2 nasopharyngeal testing in a rural community sample susceptible of first infection: the CHRIS COVID-19 study
This article has 11 authors:Reviewed by ScreenIT
-
The displacement of the SARS-CoV-2 variant Delta with Omicron: An investigation of hospital admissions and upper respiratory viral loads
This article has 14 authors:Reviewed by ScreenIT
-
Humoral immune response of patients infected by earlier lineages of SARS-CoV-2 neutralizes wild types of the most prevalent variants in Brazil
This article has 12 authors:Reviewed by ScreenIT
-
Detection of SARS-CoV-2 Omicron, Delta, Alpha and Gamma variants using a rapid antigen test
This article has 4 authors:Reviewed by ScreenIT
-
EPIDEMIOLOGICAL CHARACTERISTICS AND SEVERITY OF OMICRON VARIANT CASES IN THE APHP CRITICAL CARE UNITS
This article has 86 authors:Reviewed by ScreenIT
-
Association of Increased Fluvoxamine Use with Reports of Benefit for COVID
This article has 3 authors:Reviewed by ScreenIT
-
The inactivated NDV-HXP-S COVID-19 vaccine induces a significantly higher ratio of neutralizing to non-neutralizing antibodies in humans as compared to mRNA vaccines
This article has 25 authors:Reviewed by ScreenIT
-
Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections
This article has 23 authors:Reviewed by ScreenIT